VIMA Therapeutics
Latest round
- Series A
Last raised
- Mar 2026
Total raised
- $100M
Investors
- 4
About VIMA Therapeutics
Founded by CEO Bernard Ravina,VIMA Therapeutics is a biotechnology company headquartered in Cambridge, US, specializing in the development of therapies for movement disorders. Established with the aim of addressing unmet medical needs, the company has evolved its strategy to focus on a first-in-class oral medication for dystonia, which is currently in development. VIMA Therapeutics specializes in developing innovative treatments for dystonia and related movement disorders, focusing on a first-in-class oral medication.S. suffering from dystonia, including more than 100,000 with isolated dystonia. This medication targets specific neurological pathways involved in movement disorders, offering a promising alternative to existing therapies. VIMA Therapeutics plans to distribute its products across the United States, primarily through neurological clinics, hospitals, and specialized healthcare providers, while also educating healthcare professionals and patients on treatment options available for movement disorders. VIMA Therapeutics generates revenue through direct sales of its flagship oral medicine marketed to healthcare providers and institutions specializing in neurological disorders. The transaction model is characterized as B2B, where healthcare providers purchase the medication directly for patient use, ensuring access to innovative treatment solutions. The company may also establish partnerships with pharmaceutical distributors to expand its reach within the healthcare ecosystem. Revenue is driven by the demand for effective dystonia therapies, with transactions aligned with established pricing plans, reflecting the company’s commitment to making treatments accessible to patients in need.
Who invested in VIMA Therapeutics
4 investors across 3 rounds
See all investors in VIMA Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about VIMA Therapeutics
Who invested in VIMA Therapeutics?
VIMA Therapeutics has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has VIMA Therapeutics raised?
VIMA Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did VIMA Therapeutics last raise money?
VIMA Therapeutics's most recent round on record is a Series A, in Mar 2026.
What does VIMA Therapeutics do?
Founded by CEO Bernard Ravina,VIMA Therapeutics is a biotechnology company headquartered in Cambridge, US, specializing in the development of therapies for movement disorders.
Where is VIMA Therapeutics headquartered?
VIMA Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like VIMA Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at VIMA Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like VIMA Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.